Mutant ndp kinases for antiviral nucleotide analog...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/54 (2006.01) A61K 31/7052 (2006.01) A61K 31/7115 (2006.01) A61K 38/45 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) C07K 16/00 (2006.01) C12N 5/10 (2006.01) C12N 9/12 (2006.01) C12N 15/66 (2006.01) C12P 21/00 (2006.01)

Patent

CA 2382470

A polypeptide having a nucleoside or nucleotide kinase activity, which comprises a wild-type nucleoside or nucleotide kinase mutated at at least one amino acid position within the active site of nucleoside or nucleotide kinase to increase kinase catalytic activity towards a given nucleotide or nucleoside analog compared to the wild-type nucleoside or nucleotide kinase. A polynucleotide coding for said polypeptide. Methods, including therapeutic ones, using said polypeptide and polynucleotide.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mutant ndp kinases for antiviral nucleotide analog... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutant ndp kinases for antiviral nucleotide analog..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant ndp kinases for antiviral nucleotide analog... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1975126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.